Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Maximize your trial’s chances of success with best-in-class clinical trial data and benchmarks.
An effective clinical drug development program strategy requires optimal trial protocol development, operations planning and execution and a clear understanding of the clinical trial landscape. To support success and understand the competition, you need access to relevant, timely clinical trial data and trial benchmarks.
You also need to know where you can find reliable details of competitor and comparator trials as well as information on investigators and sites.
How we can help
It can be very time-consuming to source, review, and analyze available clinical trial data. Parsing through large amounts of information to find the relevant and key insights can also be a frustrating task.
Our easy-to-use products help you quickly filter thousands of trials to find the most relevant set to inform your trial and program strategy – from protocol design to country and principal investigator selection.
We’ll also help you:
Over 450,000 investigators from 170,000+ sites in 180+ countries, all with clinical trial experience, at your fingertips. Support your trial success and inform your principal investigator (PI) and site selection activities with Sitetrove.
Key benefits:
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Key benefits:
Trial Results Summaries
25 Nov 2022
What Are Trial Results Summaries and Why Are They Necessary?
Topic Clinical Trials
Trial Results Summaries
25 Nov 2022
Trial Results Summaries provides an unbiased and non-promotional portal for sponsors to share trial results summaries, also known as plain language summaries (PLS), with participants and the public.
Topic Clinical Trials
Citeline, Trialtrove
25 Nov 2022
Our annual analysis dissects the data of all Phase I–III clinical trials that started in a year dominated by COVID-19.
Topic Coronavirus
Citeline Connect
06 Oct 2022
In creating custom websites that share information about clinical trials, Citeline Connect recognized the need to incorporate the patient voice during the design stage. Citeline Connect partnered with Savvy Cooperative, which assembled a patient panel to provide candid feedback on the end-user experience.
Trialtrove
06 Oct 2022
Takes a deep dive into the clinical trial landscape in the Asia-Pacific (APAC) region over the past decade, from 2012 to 2021. APAC has become a hotspot for clinical trials, with trial activity trending upwards and eventually contributing almost half of the entire global clinical trial activity in 2021
Citeline Connect
23 Aug 2022
Here's look at five top trends shaping the pharmaceutical industry, assessing their impact on patient engagement and recruitment.
Citeline
27 Jun 2022
Take a look at the evolution of pharma R&D and in this article, examine the state of play at the start of 2022.
Citeline
27 Jun 2022
As the COVID-19 pandemic stretched through a second year, its impacts continued to reshape the clinical trials landscape.
Topic Clinical Trials
TrialScope Disclose
16 Jun 2022
Europe’s new Clinical Trial Information System (CTIS), created by the European Medicines Agency (EMA), is due to be implemented in January 2022. Find out what sponsors must do to ensure compliance with this far-reaching new regulatory requirement.
Topic Clinical Trials
TrialScope Disclose
07 Feb 2022
Disclosure requirements are numerous and ever evolving. Study sponsors need a transparency policy that addresses disclosure, transparency, and data sharing.
Topic Policy & Regulation
TrialScope Disclose
11 Jan 2022
Des changements majeurs arrivent, impactant toutes les étapes des essais cliniques, y compris les essais nouveaux et en cours – êtes-vous prêt ? Sachez à quoi vous attendre et comment maintenir votre conformité en matière de divulgation lorsque le nouveau système d'information sur les essais cliniques (CTIS), créé par l'Agence européenne des médicaments (EMA), entrera en vigueur.
TrialScope Disclose
14 Sep 2021
Created by the European Medicines Agency (EMA). Stakeholders will use CTIS to: Submit and approve clinical trial applications (CTAs), Submit trial reports, results and notifications, Communicate centrally with the Member States Concerned (MSC) in the clinical trial
Topic Policy & Regulation Clinical Trials Clinical Trials Blog
Citeline Connect
22 Jul 2021
Informa Pharma Intelligence partnered with Rare Patient Voice to measure the pulse of the public in relation to clinical trial participation post-COVID-19
Topic Clinical Trials
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Speak to Sales
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
